Cellebrite DI (CLBT) Operating Leases (2022 - 2025)

Cellebrite DI's Operating Leases history runs 4 years deep, the most recent figure standing at $22.7 million for Q4 2025.

• On a quarterly basis, Operating Leases rose 231.24% year-over-year to $22.7 million in Q4 2025; TTM through Dec 2025 was $22.7 million, a 231.24% increase from a year earlier, with the FY2025 full-year figure at $22.7 million, up 231.24% from the prior year.
• Operating Leases grew to $22.7 million in Q4 2025 per CLBT's latest filing, from $6.8 million in the prior quarter.
• Across five years, Operating Leases topped out at $22.7 million in Q4 2025 and bottomed at $6.8 million in Q4 2024.
• The 4-year median for Operating Leases is $9.8 million (2022), against an average of $12.3 million.
• Across the five-year window, Operating Leases decreased 25.26% in 2024 and surged 231.24% in 2025, its largest moves.
• Year by year, Operating Leases stood at $10.4 million in 2022, then retreated by 11.55% to $9.2 million in 2023, then dropped by 25.26% to $6.8 million in 2024, then jumped by 231.24% to $22.7 million in 2025.
• Per Business Quant, the three latest CLBT Operating Leases figures stand at $22.7 million (Q4 2025), $6.8 million (Q4 2024), and $9.2 million (Q4 2023).